NCT02423486

Brief Summary

The aim of this study is to compare the efficacy between Electromagnetic Stimulation therapy and Electromagnetic Stimulation therapy with Extracorporeal Biofeedback in Stress Urinary Incontinence patient.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
66

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2013

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2013

Completed
1.4 years until next milestone

First Submitted

Initial submission to the registry

March 24, 2015

Completed
29 days until next milestone

First Posted

Study publicly available on registry

April 22, 2015

Completed
4.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 6, 2019

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 28, 2019

Completed
Last Updated

December 2, 2019

Status Verified

November 1, 2019

Enrollment Period

5.8 years

First QC Date

March 24, 2015

Last Update Submit

November 28, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Rate comparison of complete recovery in stress pad test after 12 weeks of treatment

    Complete recovery is defined as urinary leakage below than 2 gram in stress pad test.

    12 weeks

Secondary Outcomes (5)

  • Incontinence Severity VAS at baseline,4weeks,8weeks,12weeks after treatment

    12 weeks

  • Sandvik questionnaire at baseline,4weeks,8weeks,12weeks after treatment

    12 weeks

  • Incontinence - Quality of Life questionnaire at baseline,8weeks,12 weeks after treatment

    12 weeks

  • Benefit,Satisfaction and Willingness to Continue questionnaire at 12 weeks after treatment

    12 weeks

  • Pelvic floor muscular strength at baseline,4weeks,8weeks,12weeks after treatment

    12 weeks

Study Arms (2)

Electromagnetic stimulation therapy

EXPERIMENTAL

Electromagnetic stimulation therapy group

Device: Electromagnetic stimulation therapy (BIOCON-2000)

Electromagnetic stimulation therapy with biofeedback

EXPERIMENTAL

Electromagnetic stimulation therapy with biofeedback group

Device: Electromagnetic stimulation therapy with biofeedback

Interventions

Electromagnetic stimulation therapy
Electromagnetic stimulation therapy with biofeedback

Eligibility Criteria

Age20 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Female patient with Stress Urinary Incontinence, over 20
  • Leakage over 2g in stress pad test
  • Capable of understanding and having signed the informed consent form after full discussion of the research nature of the treatment and its risks and benefits

You may not qualify if:

  • Mixed Urinary Incontinence which is dominant in urge urinary incontinence.
  • True incontinence
  • Overflow incontinence
  • Patient who had performed electric stimulation therapy,bladder training within 2 weeks before baseline.
  • Urinary tract infection found In urine test.
  • Patient who had pelvic organ prolapse.
  • Patient who had inserted pacemaker.
  • Pregnant woman, patient who have positive result in urine pregnancy test, patient who have plan pregnancy during study period.
  • Disorder in Neurosystem like stroke, multiple sclerosis, spinal injury, Parkinson's disease .
  • Patient who will participate in other clinical trial during this study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Samsung Medical Center

Seoul, 135-710, South Korea

Location

MeSH Terms

Conditions

Urinary Incontinence, Stress

Interventions

Biofeedback, Psychology

Condition Hierarchy (Ancestors)

Urinary IncontinenceUrination DisordersUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesLower Urinary Tract SymptomsUrological ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Mind-Body TherapiesComplementary TherapiesTherapeuticsBehavior TherapyPsychotherapyBehavioral Disciplines and ActivitiesFeedback, Psychological

Study Officials

  • Kyu-Sung Lee, Ph.D

    Samsung Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 24, 2015

First Posted

April 22, 2015

Study Start

November 1, 2013

Primary Completion

September 6, 2019

Study Completion

November 28, 2019

Last Updated

December 2, 2019

Record last verified: 2019-11

Locations